Tandem high-dose chemotherapy and autologous stem cell transplantation in refractory/relapsed Hodgkin's lymphoma: A monocenter prospective study-Reference-Cited by-同舟云学术

Tandem high-dose chemotherapy and autologous stem cell transplantation in refractory/relapsed Hodgkin's lymphoma: A monocenter prospective study

Published:2007 Issue:2 Volume:82 Page:122-127
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Castagna Luca,Magagnoli Massimo,Balzarotti Monica,Sarina Barbara,Siracusano Licia,Nozza Andrea,Todisco Elisabetta,Bramanti Stefania,Mazza Rita,Russo Filippo,Timofeeva Inna,Santoro Armando

Publisher

Wiley

Subject

Hematology

Reference33 articles.

1. High-Dose Cyclophosphamide, Carmustine, and Etoposide and Autologous Bone Marrow Transplantation for Relapsed Hodgkin's Disease

2. Successful treatment of refractory Hodgkin's disease by high-dose combination chemotherapy and autologous bone marrow transplantation

3. Treatment of progressive Hodgkin's disease with intensive chemoradiotherapy and autologous bone marrow transplantation

4. High-dose cytotoxic therapy and bone marrow transplantation for relapsed Hodgkin's disease.

5. The place of high-dose BEAM therapy and autologous bone marrow transplantation in poor-risk Hodgkin's disease. A single-center eight- year study of 155 patients

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of transplantation in Hodgkin lymphoma;Frontiers in Oncology;2023-01-26

2. Oral cryotherapy for management of chemotherapy‐induced oral mucositis in haematopoietic cell transplantation: a systematic review;BMC Cancer;2022-04-22

3. Strategies to improve outcomes of autologous hematopoietic cell transplant in lymphoma;Bone Marrow Transplantation;2018-11-02

4. Chemotherapy protocols and incidence of oral mucositis. An integrative review;Einstein (São Paulo);2018-04-23

5. Tandem haematopoietic stem cell transplantation for High Risk relapsed/refractory Hodgkin Lymphoma: a LYSA study;British Journal of Haematology;2018-04-02